GLSYNTHESIS INC has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are GALENEA CORP, VASTOX PLC and SPINIFEX PHARM PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Preservation of human bodies | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wright George E | 8 |
#2 | Xu Wei-Chu | 7 |
#3 | Brown Neal C | 4 |
#4 | Carruthers Anthony | 3 |
#5 | Wright George Edward | 3 |
#6 | Melchior Donald L | 3 |
#7 | Yanachkov Ivan Borissov | 2 |
#8 | Yanachkov Ivan | 1 |
#9 | Yanachkov Ivan Borissovich | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011031935A1 | Selective antibacterials for clostridium difficile infections | |
CA2747188A1 | Antithrombotic diadenosine tetraphosphates and related analogs | |
WO2008024169A1 | Reactive pyrophosphoric and bisphosphonic acid derivatives and methods of their use | |
US6926763B2 | Purine and isosteric antibacterial compounds | |
WO02101364A1 | Lipid structures and uses thereof |